Sotio, Prague , Czech Republic ; Department of Immunology; 2nd Faculty of Medicine; Charles University; Motol University Hospital ; Prague, Czech Republic.
Department of Otorhinolaryngology and Head and Neck Surgery; 1st Faculty of Medicine; Charles University and Motol University Hospital ; Prague, Czech Republic ; Institute of Microbiology ASCR ; Prague, Czech Republic.
Oncoimmunology. 2015 Jan 30;4(1):e965570. doi: 10.4161/21624011.2014.965570. eCollection 2015 Jan.
Human papillomavirus (HPV) infection is one of the most important etiologic causes of oropharyngeal head and neck squamous cell carcinoma (HNSCC). Patients with HPV-positive HNSCC were reported to have a better clinical outcome than patients with HPV-negative cancers. However, little is known about the possible causes of different clinical outcomes. In this study, we analyzed a detailed immune profile of tumor samples from HNSCC patients with respect to their HPV status. We analyzed the characteristics of immune cell infiltrates, including the frequency and distribution of antigen-presenting cells and naïve, regulatory and effector T cells and the cytokine and chemokine levels in tumor tissue. There was a profound difference in the extent and characteristics of intratumoral immune cell infiltrates in HNSCC patients based on their HPV status. In contrast to HPV-negative tumor tissues, HPV-positive tumor samples showed significantly higher numbers of infiltrating IFNγ CD8 T lymphocytes, IL-17 CD8 T lymphocytes, myeloid dendritic cells and proinflammatory chemokines. Furthermore, HPV-positive tumors had significantly lower expression of mRNA and higher expression of PD1 mRNA compared to HPV-negative tumors. The presence of a high level of intratumoral immune cell infiltrates might play a crucial role in the significantly better response of HPV-positive patients to standard therapy and their favorable clinical outcome. Furthermore, characterization of the HNSCC immune profile might be a valuable prognostic tool in addition to HPV status and might help identify novel targets for therapeutic strategies, including cancer immunotherapy.
人乳头瘤病毒(HPV)感染是口咽头颈部鳞状细胞癌(HNSCC)最重要的病因之一。与 HPV 阴性癌症患者相比,HPV 阳性 HNSCC 患者的临床预后更好。然而,对于不同临床结局的可能原因知之甚少。在这项研究中,我们根据 HPV 状态分析了 HNSCC 患者肿瘤样本的详细免疫图谱。我们分析了免疫细胞浸润的特征,包括抗原呈递细胞和幼稚、调节和效应 T 细胞的频率和分布,以及肿瘤组织中的细胞因子和趋化因子水平。HPV 状态不同的 HNSCC 患者肿瘤内免疫细胞浸润的程度和特征存在显著差异。与 HPV 阴性肿瘤组织相比,HPV 阳性肿瘤样本中浸润的 IFNγ CD8 T 淋巴细胞、IL-17 CD8 T 淋巴细胞、髓样树突状细胞和促炎趋化因子数量明显更高。此外,与 HPV 阴性肿瘤相比,HPV 阳性肿瘤的 mRNA 表达水平明显降低,PD1 mRNA 表达水平明显升高。高水平的肿瘤内免疫细胞浸润可能在 HPV 阳性患者对标准治疗的反应显著更好及其良好的临床结局中发挥关键作用。此外,HNSCC 免疫图谱的特征除了 HPV 状态外,可能是一种有价值的预后工具,并可能有助于确定新的治疗策略靶点,包括癌症免疫治疗。